ARTICLES|ONLINE FIRST Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study Samuel Channon-Wells, Ortensia Vito, Andrew J McArdle, et al. Lancet Rheumatol Published:February 14, 2023 DOI:https://doi.org/10.1016/S2665-9913(23)00029-2 Summary Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infe...

ARTICLES|ONLINE FIRST Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022 Nana Wu, Keven Joyal-Desmarais, Paula A B Ribeiro, et al. Lancet Respir Med Published: February 10, 2023 DOI:https://doi.org/10.1016/S2213-2600(23)00015-2 Summary Background Synthesising evidence on the long-term vaccine effect...

ARTICLES|ONLINE FIRST Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials Alain Amstutz, Benjamin Speich, France Mentré, et al. Lancet Respir Med Published:February 21, 2023 DOI:https://doi.org/10.1016/S2213-2600(22)00528-8 Summary Background Interpretation of the evidence from randomised controlled trials (RCTs) of remdesivir in patients treated in...

ARTICLES|ONLINE FIRST Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials Zhi-Rong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al. Lancet Microbe Published: February 28, 2023 DOI:https://doi.org/10.1016/S2666-5247(22)00390-1 Summary Background The efficacy of SARS-CoV-2 vaccines in preventing severe COVID-19 illness and death is uncertain due to th...

ARTICLES| VOLUME 4, ISSUE 3, E179-E191, MARCH 2023 Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis Bradley J Langford, Miranda So, Marina Simeonova, et al Lancet Microbe Published:January 31, 2023 DOI:https://doi.org/10.1016/S2666-5247(22)00355-X Summary Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate antimicrobial resistance. We aimed to establish the pr...

ARTICLES| VOLUME 4, ISSUE 3, E159-E170, MARCH 2023 Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study Jinnethe Reyes, Lauren Komarow, Liang Chen, et al. Lancet Microbe 2023; 4: E159-E170 Published: February 09, 2023 DOI:https://doi.org/10.1016/S2666-5247(22)00329-9 Summary Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a gl...

ARTICLES|ONLINE FIRST Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study Neil R Aggarwal, Kyle C Molina, Laurel E Beaty, et al. Lancet Infect Dis Published: February 10, 2023 DOI:https://doi.org/10.1016/S1473-3099(23)00011-7 Summary Background Nirmatrelvir is a protease inhibitor with in-vitro activity against SARS-CoV-2, and ri...

ARTICLES|ONLINE FIRST Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study Martin Hoenigl, Jon Salmanton-García, Matthias Egger, et al Lancet Infect Dis Published: February 15, 2023 DOI:https://doi.org/10.1016/S1473-3099(22)00872-6 Summary Background The European Confederation of Medical Mycology (ECMM) collected data on epidemiology, risk factors, ...

CORRESPONDENCE|ONLINE FIRST Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen Junyuan Huang, Shi Zhao, Ka Chun Chong, et al. Lancet Infect Dis Published: February 17, 2023 DOI:https://doi.org/10.1016/S1473-3099(23)00112-3 On Dec 7, 2022, the Chinese government announced ten measures indicating the end of the zero-COVID policy, which was in effect for more than 2 years.1 Most of the stringent preventive me...

於服用口服抗病毒藥的新冠病毒住院患者中，病毒量反彈的風險因素及相關臨床結果: 一項 回顧性隊列研究 ARTICLES|ONLINE FIRST Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study Carlos K H Wong, Kristy T K Lau, Ivan C H Au, et al. Lancet Infect Dis Published: February 13, 2023 DOI:https://doi.org/10.1016/S1473-3099(22)00873-8 Summary Background Viral rebound after ...